Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 4 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Lymphoid 3Other hematologic neoplasm 2Breast 2Tumor-Agnostic 1Other solid neoplasm 1Myeloid 1Genitourinary 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Mesothelioma 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Clinical Trials, Phase I as Topic × Thoracic × Clear all
NCT04199741 2026-01-07

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

Memorial Sloan Kettering Cancer Center

Phase 1/2 Recruiting
53 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT02382406 2023-05-23

Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC

Hoosier Cancer Research Network

Phase 1/2 Terminated
46 enrolled 24 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03655834 2022-05-10

IMPROVE-III

Radboud University Medical Center

Phase 4 Completed
10 enrolled
Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡